10 results
Key Characteristics of Old and New Potassium-Binding Agents

- Dr. Edgar V. Lerma https://twitter.com/edgarvlermamd

#Potassium #Binding #KBinders #Kayexelate
New Potassium-Binding ... Agents - Dr. ... #Potassium #Binding ... KBinders #Kayexelate #Comparison ... #Table #Pharmacology
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... anticoagulant agents ... #Dosing #Oral #Anticoagulation ... #Comparison #Table ... #Pharmacology
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage

The table summarizes the recommendations for adult patients on
Hemorrhage The table ... warfarin) Direct Factor ... Antithrombotics #Anticoagulation ... ICH #Management #Pharmacology ... #Table
Table 22 provides the characteristics of various phosphate-binding agents.
#Pharmacology #Nephrology #Phosphate #Phosphorus #Binders #Comparison #Table #Disadvantages
various phosphate-binding ... agents. ... #Pharmacology #Nephrology ... Phosphorus #Binders #Comparison ... #SideEffects
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Summary table of ... - Dabigatran #anticoagulation ... #pharmacology # ... medications #doac #comparison ... #table #management
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... following risk factors ... steroids, on ASA/anticoagulation ... • Neuropathic agents ... #guide #comparison
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
Pathophysiology Anticoagulation ... the parenteral agents ... that inhibits factor ... Xa by binding to ... #Pharmacology #Pathophysiology
Evans Syndrome Pharmacology Management 
Corticosteroids
IVIg
Rituximab
Splenectomy
Azathioprine
Cyclophosphamide
Cyclosporin
Mycophenolate
Vinka-alkaloid
Plasma exchange
Transfusion
Anticoagulation
Bone marrow stimulating agents

doi:10.3390/jcm9123851

#Evans #Syndrome #Pharmacology #Management #Medications #comparison #table
Evans Syndrome Pharmacology ... exchange Transfusion Anticoagulation ... marrow stimulating agents ... #Medications #comparison ... #table
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding ... Agents to Treat ... aspiration #Potassium #Binding ... #medications #pharmacology ... #table #comparison
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
modifiable risk factors ... - Any adverse events ... event, follow ACC algorithm ... Anticoagulation ... postoperative cardiac events